Ketamine is a new treatment for depression which has not responded to other treatments. Ketamine has a brief rapid antidepressant effect demonstrated in several clinical trials over the last 15 years.
Ketamine is not a licensed treatment for depression. It is licensed as an anaesthetic and for analgesia.
We provide a paid-for service for patients who have been referred by their GP or psychiatrist. Before treatment, patients are assessed by a psychiatrist to confirm their suitability. Initial treatment consists of three ketamine infusions over three weeks. You can find out more about the cost of treatment in the relevant section.
Oxford Health NHS Foundation Trust’s ketamine service is based at Warneford Hospital, Oxford.
Last updated: 29 October, 2018